BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 25952017)

  • 1. Role of the gastrointestinal ecosystem in the development of type 1 diabetes.
    Daft JG; Lorenz RG
    Pediatr Diabetes; 2015 Sep; 16(6):407-18. PubMed ID: 25952017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the intestinal microbiota in type 1 diabetes.
    Hara N; Alkanani AK; Ir D; Robertson CE; Wagner BD; Frank DN; Zipris D
    Clin Immunol; 2013 Feb; 146(2):112-9. PubMed ID: 23314185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota.
    Gianchecchi E; Fierabracci A
    Immunol Res; 2017 Feb; 65(1):242-256. PubMed ID: 27421719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune recognition and response to the intestinal microbiome in type 1 diabetes.
    Paun A; Yau C; Danska JS
    J Autoimmun; 2016 Jul; 71():10-8. PubMed ID: 26908163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota.
    Pellegrini S; Sordi V; Bolla AM; Saita D; Ferrarese R; Canducci F; Clementi M; Invernizzi F; Mariani A; Bonfanti R; Barera G; Testoni PA; Doglioni C; Bosi E; Piemonti L
    J Clin Endocrinol Metab; 2017 May; 102(5):1468-1477. PubMed ID: 28324102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for gut microbiota in type 1 diabetes pathogenesis?
    Bibbò S; Dore MP; Pes GM; Delitala G; Delitala AP
    Ann Med; 2017 Feb; 49(1):11-22. PubMed ID: 27499366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Regulation of T Cells During Inflammation and Autoimmunity.
    Brown EM; Kenny DJ; Xavier RJ
    Annu Rev Immunol; 2019 Apr; 37():599-624. PubMed ID: 31026411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of the role of gut dysbiosis in type 1 diabetes.
    Abdellatif AM; Sarvetnick NE
    J Diabetes; 2019 Aug; 11(8):632-644. PubMed ID: 30864231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes: role of intestinal microbiome in humans and mice.
    Boerner BP; Sarvetnick NE
    Ann N Y Acad Sci; 2011 Dec; 1243():103-18. PubMed ID: 22211896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome.
    Li Y; Liu Y; Chu CQ
    Mediators Inflamm; 2015; 2015():638470. PubMed ID: 26843788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept?
    Li X; Atkinson MA
    Pediatr Diabetes; 2015 Nov; 16(7):485-92. PubMed ID: 26269193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes.
    Sorini C; Cosorich I; Lo Conte M; De Giorgi L; Facciotti F; Lucianò R; Rocchi M; Ferrarese R; Sanvito F; Canducci F; Falcone M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15140-15149. PubMed ID: 31182588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution.
    Mejía-León ME; Barca AM
    Nutrients; 2015 Nov; 7(11):9171-84. PubMed ID: 26561831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.
    Tanca A; Palomba A; Fraumene C; Manghina V; Silverman M; Uzzau S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased iNKT17 Cell Frequency in the Intestine of Non-Obese Diabetic Mice Correlates With High
    De Giorgi L; Sorini C; Cosorich I; Ferrarese R; Canducci F; Falcone M
    Front Immunol; 2018; 9():1752. PubMed ID: 30105027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut mucosa alterations and loss of segmented filamentous bacteria in type 1 diabetes are associated with inflammation rather than hyperglycaemia.
    Rouland M; Beaudoin L; Rouxel O; Bertrand L; Cagninacci L; Saffarian A; Pedron T; Gueddouri D; Guilmeau S; Burnol AF; Rachdi L; Tazi A; Mouriès J; Rescigno M; Vergnolle N; Sansonetti P; Christine Rogner U; Lehuen A
    Gut; 2022 Feb; 71(2):296-308. PubMed ID: 33593807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity.
    Vaarala O; Atkinson MA; Neu J
    Diabetes; 2008 Oct; 57(10):2555-62. PubMed ID: 18820210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.
    Needell JC; Zipris D
    Curr Diab Rep; 2016 Oct; 16(10):89. PubMed ID: 27523648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.
    Dolpady J; Sorini C; Di Pietro C; Cosorich I; Ferrarese R; Saita D; Clementi M; Canducci F; Falcone M
    J Diabetes Res; 2016; 2016():7569431. PubMed ID: 26779542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse.
    Hadjiyanni I; Li KK; Drucker DJ
    Endocrinology; 2009 Feb; 150(2):592-9. PubMed ID: 18845625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.